AbCellera, Gates Foundation partner on infectious disease treatments

Antibody company AbCellera partnered with the Bill & Melinda Gates Foundation to develop vaccines and antibody-based therapies to treat infectious diseases.

AbCellera Biologics Inc. (Vancouver, B.C.) will receive $4.8 million in funding for the two-year deal and will collaborate with Gates Foundation-funded scientists to develop therapies to prevent and treat HIV, malaria and tuberculosis...